Invasive group A streptococcal disease in metropolitan Atlanta: A population-based assessment

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 150-157

  Zurawski, Christine A ^b   Bardsley, Marysusan ^b   Beall, Bernard ^b   Elliott, John A ^b   Facklam, Richard ^b   Schwartz, Benjamin ^b   Farley, Monica M ^a  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CHICKENPOX; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NECROTIZING FASCIITIS; NEWBORN; PRIORITY JOURNAL; RISK ASSESSMENT; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; UNITED STATES;

EID: 0031827523     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514632     Document Type: Article

References (29)

1. Stevens D. Invasive group A streptococcus infections. Clin Infect Dis 1992;14:2-11.
2. Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like infections. JAMA 1993;269:384-9.
3. Holm SE, Norrby A, Bergholm AM, et al. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992;166:31-7.
4. Musser JM, Hanser AR, Kim MH, et al. Streptococcus pyogenes causing toxic shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin production. Proc Natl Acad Sci USA 1991;88:2668-72.
5. Kiska DL, Thiede B, Caracciolo J, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997;176:992-1000.
6. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-53.
7. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996;10:571 - 81.
8. Moody MD, Padula J, Lizama D, et al. Epidemiologic characterization of group A streptococci by T-agglutination and M-precipitation tests in the public health laboratory. Health Lab Sci 1965;2:149-62.
9. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996;34:953-8.
10. Whatmore AM, Kehoe MA. Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulons. Mol Microbiol 1994;11:363-74.
11. Black CM, Talkington D, Messmer TO, et al. Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction. Mol Cell Probes 1993;7:255-9.
12. Kim YB, Watson DW. A purified group A streptococcal pyrogenic exotoxin. J Exp Med 1970;131:611-28.
13. Hauser AR, Stevens DL, Kaplan EL, et al. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991;29:1562-7.
14. Working Group on Severe Streptococcal Infections. Defining the group A toxic shock syndrome. JAMA 1993;269:390-1.
15. Colman G, Tanna A, Efstratiou A, et al. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993;39:165-78.
16. Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive S. pyogenes isolates with clinical components of STSS. Infect Immun 1993;61:3369-74.
17. Janoff EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24.
18. Abraham G. Streptococcus pyogenes peritonitis associated with genital swelling and gastroenteritis caused by Cryptosporidium and Salmonella paratyphi B in an HIV-infected patient on CAPD. Nephrol Dial Transplant 1995;10:140-1.
19. Carlin EM, Coker RJ, Shafi S, et al. Group A beta haemolytic streptococcal proctitis in an HIV-positive man. Int J STD AIDS 1994;5:144-5.
20. McNutt LA, Casiano-Colon AI, Coles FB, et al. Two outbreaks of primarily noninvasive group A streptococcal disease in the same nursing home, New York, 1991. Infect Control Hosp Epidemiol 1992;13:748-51.
21. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992;15:277-83.
22. Auerbach SB, Schwartz B, Williams D, et al. Outbreak of invasive group A streptococcal infections in a nursing home. Arch Intern Med 1992;152:1017-22.
23. Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 1991;84:785-7.
24. Rimailho A, Riou B, Richard C, et al. Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis 1987;155:143-5.
25. Brun-Buisson CJ, Saada M, Trunet P, et al. Haemolytic streptococcal gangrene and nonsteroidal anti-inflammatory drugs. BMJ 1985;290:1786.
26. Pillans PI, O'Connor N. Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann Pharmacother 1995;29:264-6.
27. McGeer A, Green K, Schwartz B, et al. Do non-steroidal anti-inflammatory drugs (NSAIDS) predispose to severe disease due to group A streptococci (GAS)? - Evidence from population based surveillance, Ontario, Canada, 1992-1995. In: Program and abstracts of the International Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
28. Carpetis J, Robins-Browne R, Martin D, et al. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiologic features and identification of a new virulent M-nontypeable clone. Clin Infect Dis 1995;21:1220-7.
29. Forni AL, Kaplan EL, Schleivert PM, et al. Clinical and microbiologic characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. Clin Infect Dis 1996;21:333-40.